| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.085 | 0.09 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.087 | 0.09 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |